Jason Robertson
Fondatore presso Nimbus Synergies, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Paul Geyer | M | 61 |
Alavida Health Ltd.
 Alavida Health Ltd. Medical/Nursing ServicesHealth Services Alavida Health Ltd. provides treatment for alcohol use disorder. The company was founded by Elliot Stone, Diane Rothon and Terri-Lynn MacKay and is headquartered in Vancouver, Canada.
Nimbus Synergies, Inc.
 Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | 7 anni |
| Jason Robertson | - | - |
University of British Columbia
McGill University
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | 15 anni |
| Morgan P. W. Sturdy | M | 71 |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | - |
| Kathryn Hayashi | F | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | 7 anni |
| Thomas English | M | 51 |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | - |
| Darrell Elliott | M | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | 8 anni |
| Bryan Statham | M | - |
LifeBooster, Inc.
 LifeBooster, Inc. Miscellaneous Commercial ServicesCommercial Services LifeBooster, Inc. operates an open-innovation platform technology company operating at the intersection of data analytics, industrial IoT and Insurtech. The company was founded by Bryan Statham, Stacey Wallin and Lawrence Chee and is headquartered in Vancouver, Canada. | - |
| Lawrence Chee | M | - |
LifeBooster, Inc.
LifeBooster, Inc. Miscellaneous Commercial ServicesCommercial Services LifeBooster, Inc. operates an open-innovation platform technology company operating at the intersection of data analytics, industrial IoT and Insurtech. The company was founded by Bryan Statham, Stacey Wallin and Lawrence Chee and is headquartered in Vancouver, Canada. | - |
| Mike Benna | M | - |
Blue Mesa Health, Inc.
 Blue Mesa Health, Inc. BiotechnologyHealth Technology Blue Mesa Health, Inc. engages in the provision of digital therapeutics program to support the prevention diabetes and other chronic diseases. The company was founded by Misa Nuccio, Curtis Duggan, Evan Willms, Mike Benna, Jonathan Bixby, and Joshua Bixby in 2015 and is headquartered in New York, NY. | 9 anni |
| Curtis Duggan | M | - |
Blue Mesa Health, Inc.
Blue Mesa Health, Inc. BiotechnologyHealth Technology Blue Mesa Health, Inc. engages in the provision of digital therapeutics program to support the prevention diabetes and other chronic diseases. The company was founded by Misa Nuccio, Curtis Duggan, Evan Willms, Mike Benna, Jonathan Bixby, and Joshua Bixby in 2015 and is headquartered in New York, NY. | 9 anni |
| Misa Nuccio | F | - |
Blue Mesa Health, Inc.
Blue Mesa Health, Inc. BiotechnologyHealth Technology Blue Mesa Health, Inc. engages in the provision of digital therapeutics program to support the prevention diabetes and other chronic diseases. The company was founded by Misa Nuccio, Curtis Duggan, Evan Willms, Mike Benna, Jonathan Bixby, and Joshua Bixby in 2015 and is headquartered in New York, NY. | 9 anni |
| Merritt Mathew | M | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | 2 anni |
| Christina Schroeder | F | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | - |
| Alfred Sequeira | M | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | - |
| David Porte | M | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | - |
| Laura Cassin | F | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | 7 anni |
| David M. Liu | M | 50 |
University of British Columbia
| 16 anni |
| Mark Ware | M | - |
McGill University
| 23 anni |
| Jan Peeters | M | 72 |
McGill University
| 25 anni |
| Sacha Mann | F | - |
Blue Mesa Health, Inc.
Blue Mesa Health, Inc. BiotechnologyHealth Technology Blue Mesa Health, Inc. engages in the provision of digital therapeutics program to support the prevention diabetes and other chronic diseases. The company was founded by Misa Nuccio, Curtis Duggan, Evan Willms, Mike Benna, Jonathan Bixby, and Joshua Bixby in 2015 and is headquartered in New York, NY. | 6 anni |
| Michael Ball | M | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | 2 anni |
| Greg Peet | M | 70 |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | - |
| David Main | M | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | - |
| Douglas Harding Mitchell | M | 85 |
University of British Columbia
| 14 anni |
| Harrison Nancy | F | - |
Nimbus Synergies, Inc.
Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| David Phillips | M | - |
McGill University
University of British Columbia
| 8 anni |
| Robert E. Pelzer | M | 70 |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 6 anni |
| Mark Monaghan | M | - |
McGill University
| 11 anni |
| Helge Seetzen | M | - |
University of British Columbia
| 11 anni |
| Ali Kashani | M | 39 |
University of British Columbia
| 3 anni |
| Sean Nolan | M | 56 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 4 anni |
| Issa Azar | M | - |
McGill University
| 5 anni |
| Noah Russell Billick | M | - |
McGill University
| 5 anni |
| Jeff Hunter | M | - |
University of British Columbia
| 6 anni |
| Isaac Langleben | M | - |
McGill University
| 7 anni |
| Wen Chuan Zhou | F | 41 |
University of British Columbia
| 5 anni |
| Philippe Savard | M | - |
McGill University
| 5 anni |
| Gabriel Fung | M | - |
University of British Columbia
| 7 anni |
| Nick B. Drake | M | - |
University of British Columbia
| 10 anni |
| Shelley McCloskey | F | 64 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 3 anni |
| Elaine Jones | M | 69 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 5 anni |
| Jonathan Yeh | M | - |
McGill University
| 12 anni |
| Michael Alan Soss | M | - |
McGill University
| 5 anni |
| Gary Bridger | M | 61 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 6 anni |
| Stephan Robert Patten | M | - |
McGill University
| 9 anni |
| Todd Simpson | M | 63 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | - |
| Tanya Sam | F | - |
McGill University
| - |
| Junaid Subhan | M | - |
McGill University
| 8 anni |
| Ben De Wit | M | - |
University of British Columbia
| 7 anni |
| Drew Taylor Callander | M | - |
McGill University
| 4 anni |
| Salman Rizvi | M | - |
University of British Columbia
| 4 anni |
| Krystal Chong | F | - |
McGill University
| 4 anni |
| Craig Jerusalim | M | - |
McGill University
| 4 anni |
| Andrew Gary Moffs | M | - |
McGill University
| 4 anni |
| Ka Man Lo | M | 45 |
McGill University
| 4 anni |
| Judy Su | F | - |
University of British Columbia
| 4 anni |
| Serdar Kabaca | M | - |
University of British Columbia
| 3 anni |
| Erik Groot | M | - |
McGill University
| 4 anni |
| Elias Ponvert | M | - |
McGill University
| 4 anni |
| Anna Fan | M | - |
McGill University
| 4 anni |
| Olivier Desmarais | M | - |
McGill University
| 4 anni |
| Moulay Mhamed Elalamy | M | 35 |
University of British Columbia
| 4 anni |
| Yan Truong | M | - |
McGill University
| 4 anni |
| Max Peters | M | - |
University of British Columbia
| 3 anni |
| Antoine Lourtau | M | - |
McGill University
| 5 anni |
| Simon Fan | M | 43 |
University of British Columbia
| 3 anni |
| Liliana Wong | F | - |
University of British Columbia
| 4 anni |
| Aaron Lipton | M | - |
McGill University
| 4 anni |
| Melissa Reiter | F | - |
McGill University
| 3 anni |
| Vikas Ranjan | M | 52 |
McGill University
| 2 anni |
| Rob J. Zeidel | M | - |
McGill University
| 4 anni |
| Heather E. L. Munroe-Blum | M | 73 |
McGill University
| 10 anni |
| Paul Alexander Balfour | M | - |
McGill University
| 3 anni |
| Sean Macdonald Driscoll | M | - |
McGill University
| 4 anni |
| Justin Flowerday | M | - |
McGill University
| 4 anni |
| Kenzie Lee Shaw | F | - |
McGill University
| 4 anni |
| Stacey Mowbray | F | 62 |
LifePilot
| - |
| Anupam K. Palit | M | - |
McGill University
| 4 anni |
| Simon Lockie | M | - |
McGill University
| 3 anni |
| Kosta Kostic | M | 50 |
McGill University
| 4 anni |
| Mayur Narin Manmohansingh | M | - |
McGill University
| 4 anni |
| Rob LeBlanc | M | - |
McGill University
| 4 anni |
| Seb Cervinka | M | - |
McGill University
| 4 anni |
| Barry Leipsic | M | - |
McGill University
| 4 anni |
| Elliot J. Shapiro | M | - |
McGill University
| 3 anni |
| Justin Campeau | M | - |
McGill University
| 4 anni |
| Graeme Jennings | M | - |
McGill University
| 4 anni |
| Tong Tong Zhao | F | 57 |
McGill University
| 2 anni |
| Andrew Gillin | M | - |
McGill University
| 4 anni |
| Dan Solomon | M | - |
McGill University
| 4 anni |
| Nick Perkell | M | - |
McGill University
| 4 anni |
| Paul Farr | M | - |
McGill University
| 3 anni |
| Guillaume Gilliard | M | - |
McGill University
| 4 anni |
| Matthew James Ruban | M | - |
McGill University
| 4 anni |
| Sandy Lam | F | - |
University of British Columbia
| 4 anni |
| Rahim A. Ladak | M | - |
McGill University
| 3 anni |
| Elizabeth Combeer | F | - |
McGill University
| 4 anni |
| Salim Ben Mansour | M | - |
McGill University
| 3 anni |
| Ben Dusastre | M | - |
McGill University
| 4 anni |
| Kwame Boateng | M | - |
University of British Columbia
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Canada | 96 | 96.00% |
| Stati Uniti | 4 | 4.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Jason Robertson
- Contatti personali
